Intercos (ICOS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jun, 2026Executive summary
Achieved record Q2 2024 with Adjusted EBITDA of €43.2M (+15% YoY) and net sales of €278.9M (+9.9% YoY), offsetting Q1 cyber attack impacts.
H1 2024 net sales reached €499.9M (+2.4% YoY); Adjusted EBITDA was €64.0M (–5% YoY), with net profit at €17.9M (–28.5% YoY) and adjusted net profit at €22.9M (–14.9% YoY), mainly due to Q1 disruption and higher D&A and taxes.
Order book at end of June 2024 up 13% YoY, with strong order intake and increased exposure to prestige customers.
Awarded EcoVadis Platinum medal for ESG for third consecutive year, ranking in the top 1% of the sector.
Expansion underway in Korea and China, with new commercial/research presence in India to capture future growth.
Financial highlights
Q2 net sales: €278.9M (+9.9% YoY); H1 net sales: €499.9M (+2.4% YoY); Q2 Adjusted EBITDA: €43.2M (+15% YoY, margin 15.5%).
H1 Adjusted EBITDA margin: 12.8% (down 99bps YoY); H1 gross margin: 20.0% (down 67bps YoY).
H1 net income: €17.9M (–28.5% YoY); H1 Adjusted net income: €22.9M (–14.9% YoY).
H1 operating cash flow: €23.2M (+€15.7M YoY); net financial debt at €114.1M, improved by €8.6M YoY; leverage ratio at 0.85x.
Investments in tangible and intangible assets: €23.8M in H1 2024.
Outlook and guidance
FY2024 sales expected to grow 6–8% vs. 2023; H2 sales forecasted to rise 10–13% YoY, outpacing global beauty market.
Order book at June 2024 up 13% YoY, with continued strong order intake and increased prestige customer share.
EMEA and Asia expected to maintain strong growth; Americas may recover in H2 despite market volatility.
H2 EBITDA margin expected in the 15–15.5% range, similar to Q2.
Latest events from Intercos
- Strong Make-up growth drove sales and margin gains, despite net profit pressure from FX.ICOS
Q2 20258 Jun 2026 - Q1 2026 sales fell 6.3% at constant FX, but strong orders and innovation support a positive outlook.ICOS
Q1 20267 May 2026 - Record profitability and margin expansion achieved in 2025; growth expected in 2026.ICOS
Q4 20254 Mar 2026 - Adjusted EBITDA up 12.3% in 9M25, with Make-up driving growth and margin improvement.ICOS
Q3 20253 Feb 2026 - Q3 sales and EBITDA up over 12%, driven by Asia and EMEA, with margin pressure ongoing.ICOS
Q3 202416 Jan 2026 - 2024 sales up 8% to €1.06bn, EBITDA up 4.3%, and 2025 growth guided at 5–7%.ICOS
Q4 20242 Dec 2025 - Q1 2025 sales up 13.4% and EBITDA up 40.6%, driven by Make-up and multinational demand.ICOS
Q1 202526 Nov 2025